Resources:

Find resources by:

Sort by:

Date Resource A-Z Random

Resources from the last:

Box size:

Filer text box:

Topic familiarity:

Grid Layout:

Collections that use this topic:

Collection topics:

Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

BiosciAlliance - Conditions Eye Disease

Obesity Diabetes Acromegaly Diabetes Insipidus Endometriosis Prostate Rare Disease Eye Disease Growth

Thyroid Eye Disease Charitable Trust

COVID-19 vaccination associated with risk of thyroid associated eye disease

Breakthrough AI system may improve treatment of debilitating diseases

European and US experts disagree on thyroid eye disease treatment

Tell your patients about this information day on the new thyroid guidelines

Tell your patients about this information day on the new thyroid guidelines

HRT may protect against glaucoma

Autumn issue of The Endocrinologist now available online

Youths with type 2 diabetes develop complications more often than type 1 peers

The Fight for Sight/British Thyroid Foundation Small Grant Award

Contact lens sensor safe for patients with thyroid eye disease

Consultant in endocrinology – Hull Royal Infirmary, Hull, UK

British Thyroid Foundation Awards 2014

Ophthalmology research funding

Osteoporosis drugs may increase risk of serious eye disease (EurekAlert, 2 April 2012)

NIHR clinical lectureships in diabetes & endocrinology, UCL

New articles added to You & Your Hormones

Grants Assistant (part-time), Fight for Sight

NIHR Health Technology Assessment programme - commissioned calls for proposals

International Symposium on Graves' Orbitopathy

Consultant in Diabetes, Endocrinology and Acute General Medicine, Bristol

Fight for Sight Eye: Research Officer

CIRTED (Combined Immunosuppression and Radiotherapy in Thyroid Eye Disease) Treatment Trial - still recruiting patients

Resource not read: Query Programmes

Resource not read: Query You and Your Hormones

The patient experience of services for thyroid eye disease in the United Kingdom: a questionnaire survey

A qualitative study of patients experience of thyroid eye disease

Reconsidering the role of thyroidectomy in thyroid eye disease (TED) patients

Occupational disability and access to psychological tools in thyroid eye disease

Graves eye disease developing following radioiodine treatment for toxic nodular goitre

Severe refractory active thyroid eye disease: an unmet clinical need in Europe

Environmental factors produce variation within a model of thyroid eye disease

The negative psycho-social impact of moderately active Thyroid Eye Disease

The risk of thyroid eye disease is increased following covid-19 vaccination

Linsitinib, AN IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

The apple of my eye

Altered adrenomedullin (ADM) levels in the central nervous system (CNS) during acute experimental allergic encephalomyelitis (EAE)

Clinical progression and differential diagnosis of an uncommon delayed-onset thyroid eye disease in a patient with graves disease: a case report

Interplay between thyroid hormones, liver gene expression, and thyroid eye disease in a murine model of graves disease

The impact of dry eye disease on magnetic resonance imaging findings and quality of life in patients with graves orbitopathy

A case of severe hypothyroidism, correcting to euthyroidism through Graves disease associated with refractory thyroid eye disease

Severe sight-threatening thyroid eye disease presenting <i>de novo</i> in an euthyroid pregnant woman

<em>In vivo</em> effect of maraviroc, a CCR5 receptor antagonist, on the progression of thyroid eye disease

A case of pendred syndrome presenting due to thyroid nodule

Concomitant papillary thyroid cancer and graves' disease: an ominous association

De novo thyroid eye disease following covid vaccination several years after radioiodine therapy

The onset of thyroid eye disease in hyperthyroidism after covid-19 infection: a case report

Thyroid eye disease manifestation following radioactive iodine treatment in patients with Graves disease

Thyroid eye disease following total thyroidectomy in a complex case of graves disease with reaction to antithyroid therapy

The role of the PPAR gamma in thyroid eye disease: Possible contra-indication for thiazolidenedione therapy

A link between thyroid eye disease (TED) and diabetes?

Plasma levels and regulation by the hypothalamicpituitaryadrenal axis of Androst-5-ene-3β,7α/β,17β-triols in human

Lymphocytes immunophenotype guided treatment in a thyroid eye disease patient successfully treated with rituximab

Management of thyroid eye disease (TED) related strabismus in euthyroid patient with with negative anti thyroid antibodies

A Challenging Case of Oscillating Hashimotos thyroiditis and Hyperthyroidism

Thyroid eye disease (TED): patient demographics across three multi-disciplinary (MDT) clinics in London, UK

Prognostic factors and outcomes of intravenous glucocorticoid pulse therapy in moderate-to-severe thyroid eye disease

Glucose regulates pancreatic β cell Ca<sup>2+</sup> dynamics and connectivity <em>in vivo</em> in the anterior chamber of the mouse eye

Report of a case with new onset of thyroid eye disease following viral vector SARS-COV-2 Vaccine

Circulating MIR-146A and MIR-21 predict glucocorticoid response in thyroid eye disease

Early low dose rituximab for active thyroid eye disease: an effective and well tolerated treatment

Early use of steroid-sparing agents in treatment of moderate-to-severely active thyroid eye disease

Low dose rituximab for thyroid eye disease: an effective treatment with fall in TSH receptor antibodies (TRAb)

HPA axis integrity after Iv methylprednisolone for active moderate-to-severe thyroid eye disease

Dont forget the eye when seeing thyroid!

Utility of sPD-l1 and sPD-1 as biomarkers for assessing clinical activity in moderate-to-severe thyroid eye disease

Thyroid eye disease: online medical education unveils knowledge gaps and barriers regarding targeted immunotherapy

Thyroid eye disease: adjusting to an altered sense of identity influences patients interactions with healthcare professionals

Specific patterns of orbital-resident B and T lymphocytes are related to different clinical presentations of thyroid eye disease

Visual functioning and physical appearance quality of life (QoL) scores of Thyroid Eye Disease (TED) patients seen in a multidisciplinary consultation

Target-tissue immunophenotyping of patients with thyroid eye disease before and after therapy with steroids, tocilizumab and rituximab

Predictive factors of the response to intravenous glucocorticoids for active moderate-to-severe thyroid eye disease

FROM HYPOTHYROID TO THYROTOXIC WITH ASSOCIATED THYROID EYE DISEASE: A CASE PRESENTATION

Teprotumumab-Related adverse events in thyroid eye disease: a multi-center real world study

Histological categorization of equine ovarian follicles from healthy and diseased mares

Identify and manage thyroid eye disease early?

Optimizing clinical care of patients with Thyroid Eye Disease

Thyroid Eye Disease and Quality of Life

Webinar 4 - Thyrotoxicosis, Thyroid Eye Disease and Amiodarone-induced Thyroid disease